Eyenuk
Woodland Hills
About Eyenuk
Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance. The company's first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for the autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life-and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. The company was founded in 2010 and is based in Los Angeles, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $47.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: eyenuk.com
- Phone: +1 818 835 3585
Industries & Categories
Artificial Intelligence (AI), Diabetes, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/eyenuk-76772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.